Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Olry de Labry-Lima

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 5, 2022
Factors associated with mortality in patients hospitalized for COVID-19 in Spain. Data from the RERFAR registryAntonio Olry de Labry-Lima, Javier Saez-de la Fuente, Laila Abdel-Kader Martin, et al.
Family Practice|March 7, 2022
Feasibility of the SINERGIAPS ("Sinergias entre profesionales y pacientes para una Atención Primaria Segura") intervention for improving patient safety in primary careMaria J Serrano-Ripoll, Maria A Fiol-deRoque, José M Valderas, et al.
Bone Marrow Transplantation|June 1, 2019
Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant of hematopoietic progenitor cellsAntonio Olry de Labry Lima, Vicente Gimeno-Ballester, Rafael Ríos Tamayo, et al.
Environmental Research|August 18, 2020
Relationship between exposure to mixtures of persistent, bioaccumulative, and toxic chemicals and cancer risk: A systematic reviewNicolás Francisco Fernández-Martínez, Ana Ching-López, Antonio Olry de Labry Lima, et al.
International Journal of Environmental Research and Public Health|June 10, 2023
Educational Strategies to Reduce Physician Shortages in Underserved Areas: A Systematic ReviewAlexandre Medeiros de Figueiredo, Antonio Olry de Labry Lima, Daniela Cristina Moreira Marculino de Figueiredo, et al.
Plos One|July 31, 2019
Optimal start in dialysis shows increased survival in patients with chronic kidney diseaseAraceli Caro Martínez, Antonio Olry de Labry Lima, José Manuel Muñoz Terol, et al.
Exploratory Research in Clinical and Social Pharmacy|October 27, 2025
Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategyIngrid Ferrer López, Antonio Olry de Labry-Lima, Alicia Gutiérrez-Valencia, et al.
Plos One|October 25, 2022
Strengthening patients' triage in community pharmacies: A cluster randomised controlled trial to evaluate the clinical impact of a minor ailment serviceNoelia Amador-Fernández, Shalom I Benrimoj, Antonio Olry de Labry Lima, et al.
Breast (Edinburgh, Scotland)|April 25, 2021
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in SpainAntonio Olry de Labry Lima, Zuzana Špacírová, Silvia Fénix-Caballero, et al.
Clinical Kidney Journal|November 10, 2021
Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in SpainAntonio Olry de Labry Lima, Óscar Díaz Castro, Jorge M Romero-Requena, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 5, 2022
Factors associated with mortality in patients hospitalized for COVID-19 in Spain. Data from the RERFAR registryAntonio Olry de Labry-Lima, Javier Saez-de la Fuente, Laila Abdel-Kader Martin, et al.
Family Practice|March 7, 2022
Feasibility of the SINERGIAPS ("Sinergias entre profesionales y pacientes para una Atención Primaria Segura") intervention for improving patient safety in primary careMaria J Serrano-Ripoll, Maria A Fiol-deRoque, José M Valderas, et al.
Bone Marrow Transplantation|June 1, 2019
Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant of hematopoietic progenitor cellsAntonio Olry de Labry Lima, Vicente Gimeno-Ballester, Rafael Ríos Tamayo, et al.
Environmental Research|August 18, 2020
Relationship between exposure to mixtures of persistent, bioaccumulative, and toxic chemicals and cancer risk: A systematic reviewNicolás Francisco Fernández-Martínez, Ana Ching-López, Antonio Olry de Labry Lima, et al.
International Journal of Environmental Research and Public Health|June 10, 2023
Educational Strategies to Reduce Physician Shortages in Underserved Areas: A Systematic ReviewAlexandre Medeiros de Figueiredo, Antonio Olry de Labry Lima, Daniela Cristina Moreira Marculino de Figueiredo, et al.
Plos One|July 31, 2019
Optimal start in dialysis shows increased survival in patients with chronic kidney diseaseAraceli Caro Martínez, Antonio Olry de Labry Lima, José Manuel Muñoz Terol, et al.
Exploratory Research in Clinical and Social Pharmacy|October 27, 2025
Risk perception, attitudes, and quality of life in a multicomponent benzodiazepine deprescription strategyIngrid Ferrer López, Antonio Olry de Labry-Lima, Alicia Gutiérrez-Valencia, et al.
Plos One|October 25, 2022
Strengthening patients' triage in community pharmacies: A cluster randomised controlled trial to evaluate the clinical impact of a minor ailment serviceNoelia Amador-Fernández, Shalom I Benrimoj, Antonio Olry de Labry Lima, et al.
Breast (Edinburgh, Scotland)|April 25, 2021
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in SpainAntonio Olry de Labry Lima, Zuzana Špacírová, Silvia Fénix-Caballero, et al.
Clinical Kidney Journal|November 10, 2021
Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in SpainAntonio Olry de Labry Lima, Óscar Díaz Castro, Jorge M Romero-Requena, et al.
Pageof 6